A Randomized controlled trial of modified Respiratory Guixinggong in delaying the progression of Pulmonary dysfunction in patients with mild to moderate COPD
- Conditions
- Chronic obstructive pulmonary disease
- Registration Number
- ITMCTR2000004077
- Lead Sponsor
- Affiliated Hospital of Chengdu University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. patients aged 45-75 years with mild to moderate COPD in stable stage;
2. meet the diagnostic criteria: FEV1/FVC < 70% after using bronchodilator, and FEV1 >=50% after using bronchodilator, with a history of respiratory symptoms and / or risk factors exposure;
3. one month or more after acute attack treatment;
4. did not participate in other traditional exercise before being selected;
5. voluntarily participated in this study with informed consent and signed informed consent form;
6. those with clear consciousness and stable cardiopulmonary function.
1. patients with chronic cough and wheezing caused by tuberculosis, fungus, tumor, irritant gas, allergy and other factors; and patients diagnosed as bronchial asthma, bronchiectasis, lung cancer, congestive heart failure, bronchiolitis obliterans, diffuse panbronchiolitis, bronchial keratosis, etc.;
2. patients with cardiovascular, urinary, digestive, blood, endocrine and other serious primary diseases and inability to cooperate with spirit, intelligence or even thinking;
3. pregnant or lactating women;
4. patients who are participating in other clinical trials;
5. researchers believe that other reasons are not suitable for clinical trials.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function;
- Secondary Outcome Measures
Name Time Method Modified Medical Research Council Dyspnea Scale;Six-minute walk test;BODE index;Serum interleukin-8;COPD assessment test (CAT);Serum C-reactive protein;Six-minute walk test;Exhaled nitric oxide concentration;